NASDAQ:ORMP
Oramed Pharmaceuticals Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.oramed.comipo date
May 01, 2007
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with d...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus